In the last 12 months, insiders at Kailera Therapeutics, Inc. ($KLRA) filed 44 transactions with the SEC: 5 open-market purchases totaling $326,750,016 and 0 sales totaling $0. Net insider sentiment: net buying.
Kailera Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Kaplan Andrew T. (Not found) — 4 transactions totaling $134,375,008
- BAIN CAPITAL INVESTORS LLC (Not found) — 3 transactions totaling $134,375,008
- Koppel Adam (Not found) — 6 transactions totaling $25,000,000
- Bain Capital Life Sciences Investors, LLC (Not found) — 5 transactions totaling $25,000,000
- RTW INVESTMENTS, LP (Not found) — 4 transactions totaling $8,000,000
View all SEC Filings for Kailera Therapeutics, Inc. (KLRA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 20, 2026 | RTW INVESTMENTS, LP | Not found | C | Common Stock | 10276820 | $0.00 | 10,276,820.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | RTW INVESTMENTS, LP | Not found | P | Common Stock | 500000 | $16.00 | 10,776,820.0000 | 0 | 4.87% | 0.00% |
| April 20, 2026 | RTW INVESTMENTS, LP | Not found | C | Series A Preferred Stock | 8250000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | RTW INVESTMENTS, LP | Not found | C | Series B Preferred Stock | 2026820 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Common Stock | 9477719 | $0.00 | 9,477,720.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Common Stock | 2034133 | $0.00 | 2,034,134.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Series A-2 convertible preferred stock | 4968789 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Series A-2 convertible non-voting preferred stock | 708814 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | BAIN CAPITAL INVESTORS LLC | Not found | C | Common Stock | 17857143 | $0.00 | 17,857,143.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | BAIN CAPITAL INVESTORS LLC | Not found | P | Common Stock | 8398438 | $16.00 | 26,255,581.0000 | 0 | 47.03% | 0.00% |
| April 20, 2026 | BAIN CAPITAL INVESTORS LLC | Not found | C | Series B Preferred Stock | 17857143 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Koppel Adam | Not found | C | Common Stock | 16875000 | $0.00 | 16,875,000.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Koppel Adam | Not found | C | Common Stock | 4145768 | $0.00 | 21,020,768.0000 | 0 | 24.57% | 0.00% |
| April 20, 2026 | Koppel Adam | Not found | P | Common Stock | 1562500 | $16.00 | 22,583,268.0000 | 0 | 7.43% | 0.00% |
| April 20, 2026 | Koppel Adam | Not found | C | Series A-1 Preferred Stock | 16875000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Koppel Adam | Not found | C | Series B Preferred Stock | 4145768 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 16, 2026 | Koppel Adam | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Bain Capital Life Sciences Investors, LLC | Not found | C | Common Stock | 16875000 | $0.00 | 16,875,000.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Bain Capital Life Sciences Investors, LLC | Not found | C | Common Stock | 4145768 | $0.00 | 21,020,768.0000 | 0 | 24.57% | 0.00% |
| April 20, 2026 | Bain Capital Life Sciences Investors, LLC | Not found | P | Common Stock | 1562500 | $16.00 | 22,583,268.0000 | 0 | 7.43% | 0.00% |
| April 20, 2026 | Bain Capital Life Sciences Investors, LLC | Not found | C | Series A-1 Preferred Stock | 16875000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Bain Capital Life Sciences Investors, LLC | Not found | C | Series B Preferred Stock | 4145768 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Kaplan Andrew T. | Not found | C | Common Stock | 17857143 | $0.00 | 17,857,143.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Kaplan Andrew T. | Not found | P | Common Stock | 8398438 | $16.00 | 26,255,581.0000 | 0 | 47.03% | 0.00% |
| April 20, 2026 | Kaplan Andrew T. | Not found | C | Series B Preferred Stock | 17857143 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 16, 2026 | Kaplan Andrew T. | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Cloghessy Paula | Chief People Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Cloghessy Paula | Chief People Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Akamine Scott | Chief Legal Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Akamine Scott | Chief Legal Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Renaud Ronald C JR | CEO & President | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Renaud Ronald C JR | CEO & President | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Burgess Paul D. | See Remarks | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Burgess Paul D. | See Remarks | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | MILLIGAN JOHN F | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Coleman Jamie Beth | Chief Commercial Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Coleman Jamie Beth | Chief Commercial Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | MACKAY MARTIN | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Wasserman Scott M. | Chief Medical Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Wasserman Scott M. | Chief Medical Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Hite Christopher | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Clyburn Frank | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Pagan Douglas W. | Chief Financial Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Pagan Douglas W. | Chief Financial Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |